2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S125000, C548S131000, C548S136000, C548S195000, C548S215000, C548S245000, C548S255000, C548S262200, C548S300100, C548S364700, C548S465000, C546S139000, C546S152000, C546S159000, C544S180000, C544S182000, C514S415000

Reexamination Certificate

active

06987122

ABSTRACT:
2-(1H-Indol-3-yl)-2-oxo-acetamide derivatives of formula (I) having antitumor activity in particular against solid tumors, specifically colon and lung tumors.

REFERENCES:
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6693119 (2004-02-01), Nickel et al.
patent: 6753342 (2004-06-01), Menta et al.
patent: 0 490 263 (1992-06-01), None
patent: WO 99 51224 (1999-10-01), None
patent: WO 99 55696 (1999-11-01), None
patent: WO 00 67802 (2000-11-01), None
patent: WO 01 47916 (2001-07-01), None
Polymeropoulos, E. E., et al., “A Peptide Binding Site Model for PDE 4 Inhibitors”,Quant. Struct.-Act. Relat., vol. 18, No. 6 (1999) pp. 543-547.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3557166

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.